Skip to search formSkip to main contentSkip to account menu

azinomycin B

Known as: 1-Naphthalenecarboxylic acid, 3-methoxy-5-methyl-, 2-((1-(3-(acetyloxy)-4-hydroxy-1-azabicyclo(3.1.0)hex-2-ylidene)-2-((1-(hydroxymethylene)-2-oxopropyl)amino)-2-oxoethyl)amino)-1-(2-methyloxiranyl)-2-oxoethyl ester 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Azinomycin B is a hybrid polyketide/nonribosomal peptide natural product and possesses antitumor activity by interacting… 
2010
2010
Azinomycin B is a potent antitumor antibiotic that features a set of unusual, densely assembled functionalities. Among them, the… 
2004
2004
13C-labelled acetate efficiently labels the antitumour natural product azinomycin B, revealing a polyketide origin for the… 
2004
2004
Isotopically labelled intermediates in a proposed biosynthesis of the naphthoate fragment of azinomycin B have been made and… 
Highly Cited
2002
Highly Cited
2002
Evaluation of the sequence selectivity, noncovalent association, and orientation of the DNA cross-linking agent azinomycin B on… 
2002
2002
A new set of charges specifically developed for biologically relevant N7-alkylated purine adducts have been implemented in the… 
Highly Cited
2000
Highly Cited
2000
Azinomycin B (also known as carzinophilin A) contains two electrophilic functional groups-an epoxide and an aziridine residue… 
2000
2000
A computational model for the covalent interstrand DNA cross-linking of the antitumor agent azinomycin B is reported and is based… 
Highly Cited
1987
Highly Cited
1987
Azinomycins A and B, isolated from the culture broth of Streptomyces griseofuscus S 42227, were examined for antitumor activities…